Log In
BCIQ
Print this Print this
 

AR-13154

  Manage Alerts
Collapse Summary General Information
Company Aerie Pharmaceuticals Inc.
DescriptionMulti-kinase inhibitor of ROCK, JAK AND PDGFR-β
Molecular Target Janus kinase (JAK) ; Platelet derived growth factor receptor (PDGFR)
Mechanism of ActionRho kinase inhibitor; Janus kinase inhibitor; Platelet derived growth factor receptor (PDGFR) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationAge-related macular degeneration (AMD)
Indication DetailsTreat age-related macular degeneration (AMD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/05/2015

Undisclosed

0

Undisclosed

Get a free BioCentury trial today